— Know what they know.
Not Investment Advice

NCEL NASDAQ

NewcelX Ltd.
1W: -3.4% 1M: -14.9% 3M: -27.1% YTD: +36.4%
$2.85
-0.06 (-2.06%)
 
Weekly Expected Move ±7.3%
$2 $3 $3 $3 $3
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 30 · $1.3M mcap · 450000 float · 9.79% daily turnover · Short 11% of daily vol

Cash Flow Trends

Operating Cash Flow
-$4M +55.9% ▲
Capital Expenditures
$4K -97825.7% ▼
Free Cash Flow
-$4M +55.9% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$768K +109.5% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$3M-$12M-$16M-$12M-$2M
Depreciation & Amort.$72M$10K$11K$11K$3K
Stock-Based Comp.$0$0$23K$165K$126K
Change in Working Capital$2M-$3M$2M$2M$78K
Other Non-Cash Items-$72M$167K$342K$60K-$2M
Operating Cash Flow-$729K-$15M-$14M-$10M-$4M
— Investing Activities —
Capital Expenditures$0-$40K$0-$4-$4K
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$226K$0-$4M$4$0
Investing Cash Flow$226K-$40K-$4M$0-$4K
— Financing Activities —
Net Debt Issuance$1M-$2M$826K$2M$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$687K$8M$7M$0-$213K
Financing Cash Flow$504K$20M$17M$2M$5M
Net Change in Cash-$127K$5M$4M-$8M$768K
Cash End of Period$94K$5M$9M$898K$2M
Free Cash Flow-$729K-$15M-$14M-$10M-$4M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms